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Abstract Asthmaeducationalprogramshavebeen showntoreducetheuse of emergencyroom, frequencyof severe
asthma attacks andhospitalization.However, its effectivenessinothermorbidityparameters andonqualityof lifehasyet
to be fully understood.This prospective randomized control trial evaluated the effectiveness of a patienteducation pro-
gram in 77 asthmatics according to ‘‘TeachYour Patients About Asthma: AClinician’s Guide’’(1992). Forty asthmatic pa-
tientswererandomlyallocatedtoGroupA (usualtreatment) and 37 toGroup B (usualtreatmentplus apatienteducation
program).The effectiveness ofthe educationalprogramwas evaluatedbycomparingmorbidityoutcomes atbaseline and
3months after initial evaluation.Atenrolment, the two groupswerenotdifferentwithregard to age, sex, smoking, asth-
ma severity, atopy,FEV1, symptom-free days, use of rescue salbutamol and quality of life.Threemonths later, subjects in
Group B showed a significant improvement in the overall qualityof life (po0.01) and in the‘‘Symptoms’’domain (po0.01).
None of the other parameters (use of rescue salbutamol, symptom-free days, days absent fromwork or school, FEV1)
showed any significant change. After stratification for asthma severity, only subjects with moderate-to-severe asthma
showed a significant improvement in the overall quality of life (po0.05) and in the‘‘Symptoms’’ (po0.01) and ‘‘Activities’’
(po0.05) domains.Moreover, in subjectswithmoderate-to-severe asthma FEV1value atthe 3rdmonthof follow-upwas
higher in Group B thanin Group A (po0.05).In conclusion, the educationalprogramimproved the qualityof life in asth-
matic subjects, mainly inpatientswithmoderate-to-severe asthma.r2002 Elsevier Science Ltd.Allrights reserved.
Available online athttp://www.sciencedirect.com
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Asthma, a very frequent disease in children and adults,
continues to be a major cause of morbidity even though
pharmacological treatment has greatly improved in re-
cent years (1).
For this reason patient education has been used to
support the usual asthma therapy (1) with the aim of
improving patients’ knowledge about the disease and,
most of all, of encouraging a partnership between
patients and physicians.
This approach has been shown to reduce the use of
emergencyroom (2), frequency of severe asthma attacks
(2) and hospitalization (2) in very high-risk patients, and
to improvepatients’welfarewith consistent ¢nancial sav-
ings (3). However, its e¡ectiveness in other morbidity
parameters has yet to be fully understood.Received 20 November 2001, accepted in revised form 23 April 2002.
Correspondence should be addressed to:Dr Alessandra Marabini,MD,
Medicina del Lavoro eTossicologia,Via E.Dal Pozzo, 06126 Perugia, Italy.
Fax: +39 75 5783654; E-mail: modall@unipg.itThe e¡ect of an educational program on quality of life
(QOL), a parameter whose importance is currently
growing (4), has not yet been adequately investigated
(5^7).
This prospective randomized controlled trial assessed
the e¡ectiveness of an educational program in a group of
asthmatic outpatients and its impact on quality of life.
MATERIALSANDMETHODS
Subjects
Seventy-seven patients selected from outpatients at-
tending the asthma clinic, Institute of Occupational Med-
icine, University of Perugia, Italy were enrolled in the
study. All were aged18 years or over and had had a pri-
mary diagnosis of persistent asthma (mild, moderate or
severe) at least1year earlier according to the criteria of
the AmericanThoracic Society.Their asthma was stable
in the 3 months before recruitment.
Subjects were randomly allocated to two groups:
Group A (control group): usual treatment, and Group B
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program. Every e¡ort to optimize treatment in both
groups wasmade; therefore, pharmacological treatment
for each subject followed the guidelines of the American
Heart, Lung and Blood Institute (1). Every patient gave
informed consent.
Details of the subjects are shown inTable1.No di¡er-
ences were found in the two groups, even after strati¢-
cation for asthma severity (mild vs. moderate to severe).
At enrolment12 subjects (15.6%)wereunemployedor re-
tired.Only employed patients or students were included
in the analysis of days of absence from school or work.
Study design and outcomes
This study is a randomized controlled trial designed to
evaluate the e¡ectiveness of a program of patient educa-
tion in asthmatics.
Upon enrolment, only subjects in Group B took part
in an educational program (carried out by the same
GroupAphysician), based on‘‘TeachYour Patients About
Asthma: A Clinician Guide’’ (8). The three 2h sessions
included: (1) basic information about asthma; (2) informa-
tion about asthma medications (bronchodilators and anti-
in£ammatoryagents), use of inhalers andpeak£owmeters;
(3) identi¢cation of asthma-warning signs, avoidance of,
and/or reduction of exposure to asthma triggers, develop-
mentof action andemergencyplans [eachpatientwasgiven
written instructions aboutmanaging asthmatic attacks, ac-
cording to the asthmamanagement zone system (1)].Hand-
outs covering the key points of each lesson for learning
reinforcementwere distributed.TABLE 1. Patients’social, demographic and clinical data
Group A
(n=40)
Age (years)* 49.3716.8
Sex,M/F 18/22
Smokinghabits, n (%)
Nonsmokers 25 (62.5)
Ex-smokers 9 (22.5)
Current smokers 6 (15.0)
Duration of asthma (years) 14.9737.5
Atopy, n (%) 15 (37.5)
Asthma Severity, n (%)
Mildpersistent 8 (20.0)
Moderate persistent 22 (55.0)
Severe persistent 10 (25.0)
NS=not signi¢cant.
*Values aremean7SD.
Group A¼usual treatment,Group B¼usual treatment+educatioThe investigatorsmade a concerted e¡ort tomaintain
a partnership with each patient and listening was an ac-
tive part of the program. Patients were involved in deci-
sion-making with regard to therapy and were taught
how to deal with symptoms early.
Patients in the control group received instructions
from the physician on medication use, and in£uence of
allergenic and non-allergenic triggers, and were taught
how to use their inhaler properly. Explanations to speci-
¢c questions, if raised by the patients, were also given.
The e¡ectiveness of the educational program was
evaluated by comparing morbidity outcomes at baseline
and 3 months after the initial evaluation. Parameters in-
cluded symptom-free days, use of rescue salbutamol,
days absent from school or work and drug expenses.
These events were compared with those occurring in
themonth before the study period.
Disease-speci¢c quality of life was also included in the
evaluation of the e¡ectiveness by using the Asthma
Quality of Life Questionnaire (9) administered at base-
line and at the 3rd month of follow-up. The Asthma
Qualityof LifeQuestionnairehas 32 questions in fourdo-
mains: activities, emotions, symptoms, and environmen-
tal triggers.Quality of life is expressed as a score ranging
from1 (total impairment) to 7 (no impairment).We used
two methods to interpret QOL results clinically. The
¢rst one according to the recommendations of Juniper
et al. (10) stating that a di¡erence in score X0.5 is
clinically relevant for overall QOL and for each of the in-
dividual domains. The second method interprets QOL
results as expressedby the proportion of patients bene-
¢ting from the educational program (11).
Spirometry was carried out and PEF wasmeasured at
enrolment and 3months after the initial evaluation.FEV1Group B
(n=37)
p
53.1716.8 NS
18/19 NS
NS
21 (56.8)
14 (37.8)
2 (5.4)
13.4710.6 NS
12 (32.4) NS
NS
5 (13.5)
28 (75.7)
4 (10.8)
nalprogram.
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cording to the recommendations of the AmericanThor-
acic Society (12). Values are expressed as percent of
predicted values (13).
Statistical analysis
Datawere analyzedusing the Statistical Analysis System
(SAS) package for mainframe (14).Values for continuous
variables are expressed as themean7SD.Wilcoxon rank
sum test and the Chi-square test or Fisher exact test
were used, when appropriate, to compare the two
Groups (A and B) at each time point (baseline and 3rd
month of follow-up). Di¡erences in continuous variables
between baseline and the 3rd month follow-up point
were tested in each group using the two-tailed paired t-
test (when the variables were normally distributed) or
theWilcoxon signed-rank test (when the variables were
not normally distributed). Di¡erences in Group Awere
compared with those in Group B using Student’s t-test
or theWilcoxon rank sum test, when appropriate. Since
FEV1 (% predicted) at baseline was slightly higher in
Group B than in GroupA analysis of covariance (ANCO-
VA) was used to adjust FEV1 values at the 3rd month of
follow-up, and to compare the adjusted FEV1 at the 3rd
month in the two groups. The same analysis was per-
formed after strati¢cation of the subjects into two
groups according to asthma severity (mild asthma, and
moderate-to-severe asthma (1).Di¡erenceswere consid-
ered signi¢cant at po0.05.
RESULTS
Table 2 shows lung function andmorbidity parameters in
both groups at baseline and the 3rd month. Infra-group
analysis: no signi¢cant improvements in any of the out-
comes were found in Group B or Group A. During fol-
low-up subjects in Group B tended to use more rescueTABLE 2. Lung function andmorbidityparameters in the two g
Gro
Baseline
FEV1 (% predicted) 77.5718.5
PEF (1/min) 3827112
Inthe lastmonth
Days absent fromwork/school, (n) 0.170.6
Symptom-free days, (n) 21.4711.0
Rescue salbutamol (nof pu¡s) 22.9734.9
Medication expenses (US) 57.5746.1
*Po0.05 ascomparedwiththe 3rdmonthvalueinthecontrolg
values.
Group A¼usual treatment; group B¼ususal treatment+educatisalbutamol, while subjects in Group A used less rescue
salbutamol, but the di¡erences were not signi¢cant. In
particular, three of the 37 subjects in Group B reported
a marked increase, and two of the 40 subjects in
Group A a great decrease in the use of rescue salbuta-
mol. Inter-group analysis: no statistically signi¢cant dif-
ference emerged in any parameter at the 3rdmonth.
After strati¢cation for asthma severity only baseline
FEV1 (% predicted) in subjects with moderate-to-severe
asthma, was signi¢cantly higher in Group B than in
GroupA (81.2716.5 vs. 72.5716.6, po0.05). After adjust-
ing for baseline FEV1, at the 3rdmonth of follow-up FEV1
(% predicted) was higher in Group B than in Group A
(po0.05). No di¡erences were found in subjects with
mild asthma.
Results of QOL at baseline and at the 3rd month of
follow-up are shown in Fig.1.Three months after the in-
itial evaluation, subjects in Group B had a signi¢cant im-
provement in the overall QOL (from 5.770.8 to 670.7,
po0.01) and in the ‘‘Symptoms’’ domain (from 5.871.1 to
6.270.8, po0.005).Therewas no statistically signi¢cant
change in QOL in subjects in Group A. An improvement
X 0.5 in the QOL score in the overall and ‘‘Symptoms’’
domainswas found in12 and in16 subjects in group B, and
in seven and nine subjects in Group A, respectively.The
analysis to assess the number of patients that needed to
be treated (NNT) to obtain a single patient bene¢t (11)
showed that, except for the ‘‘Emotions’’ domain with an
NNTequal to 17, NNTwas similar in the other domains,
ranging from 3.1in the‘‘Symptoms’’domain, and 3.4 in the
‘‘Environment’’domain, to 4.3 in the‘‘Activities’’and over-
all domains.
At the 3rd month of follow-up Group B compared to
Group A had an higher score in the overall (670.7 vs.
5.670.9, po0.05) and in the ‘‘Environment’’ (6.670.7 vs.
671.2, po0.005) and ‘‘Symptoms (6.270.8 vs. 5.771.1,
po0.005) domains.
At the 3rd month of follow-up subjects in Group B
with moderate-to-severe asthma had a signi¢cantroups at baseline and atthe 3rdmonth of follow-up
up A Group B
3rdmonth Baseline 3rdmonth
76.2720.7 83716.5 85.4715.1*
3977130 3897118 4117109
0 0.270.9 0
22.8710.9 22.2710.9 23.079.5
16.4734.1 14.8737.8 25.8751.1
60.6748.8 62.6743.1 56.6743.8
roup, byanalysisofcovariance, after adjusting for FEV1baseline
onalprogram.
FIG. 1. Overallqualityof life and separate domainsinthetwogroups atbaseline andatthe 3rdmonthof follow-up.&,Baselinevalue;
, 3rdmonth of follow-up.
996 RESPIRATORYMEDICINEimprovement in the overall QOL score (from 5.670.8 to
670.7; po0.05) and in the ‘‘Symptoms’’ (from 5.771.1 to
6.270.8; po0.01) and ‘‘Activities’’ (from 5.170.9 to
5.470.9; po0.05) domains. In Group A subjects with
moderate-to-severe asthma QOL scores at the 3rd
month of follow-up remained unchanged. Nine, 14, and
10 subjects in Group B, and 5, 8 and 6 subjects in Group
A showed a X0.5 improvement in the overall, ‘‘Symp-
toms’’ and ‘‘Activities’’ domains, respectively. Inter-groupanalysis at the 3rdmonth of follow-up showed that sub-
jects in Group Bwith moderate-to-severe asthma had a
higher overallQOL score (670.7vs. 5.571; po0.05), and
‘‘Environment’’ (6.770.5 vs. 5.971.3; po0.005) and
‘‘Symptoms’’ domain scores (6.270.8 vs. 5.671.2;
po0.01) than subjects in Group A.
No changes in QOL were found in subjects with mild
asthma at baseline and at the 3rd month of follow-up in
either group.
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This study showed that the educational programwas ef-
fective in improving QOL, mainly in patients with mod-
erate-to-severe asthma.We observed improvements in
the overall QOL score and ‘‘Symptoms’’domain in all pa-
tients, whereas an improvement in the ‘‘Environment’’
domainwas found only in subjectswithmoderate-to-se-
vere asthma. In spite of recent awareness of the rele-
vance of health-related QOL in clinical assessments (4),
to thebest of our knowledge, the outcome ofQOL after
an educational programhas been investigated in few stu-
dies (5^7).The results of these studies concur with ours.
In fact,Turner et al. (5), Kauppinen et al. (7), and Kelso et
al. in anuncontrolled study (6) observed a signi¢cant and
rapid increase in the QOL score in subjects who partici-
pated in an educational program.
Interestingly, when we strati¢ed by severity of asth-
ma, the improvement in QOL was observed in patients
with moderate-to-severe asthma, but not in those with
mild asthma. Consequently, the educational program
was in fact e¡ective only in a subgroup, con¢rming re-
sults of other studies conducted in children (15,16). Sub-
jects with mild asthma may have higher baseline QOL
values than those with moderate-to-severe asthma. A
signi¢cant increase in QOL values is therefore di⁄cult
to obtain since these subjects have less room for im-
provement.On the other hand, because ofmultiple test-
ing, interpretation of these results should acknowledge
the risk of having signi¢cant di¡erences just by chance.
The ¢nding of a statistically signi¢cant increase in
QOL score is an important result, but does the statisti-
cal di¡erence mean a clinical di¡erence as well? The re-
cent paper by Juniper et al., the investigators who
developed the questionnaire we used (10), pointed out
that a di¡erence in scoreX0.5 is clinically important. In
our study, an inter-group clinical di¡erence was found in
subjects withmoderate-to-severe asthma in the overall,
‘‘Symptoms’’ and ‘‘Environment’’domains.Moreover, sub-
jects with moderate-to-severe asthma also showed a
clinically signi¢cant improvement from baseline to the
3rd month of follow-up in the ‘‘Symptoms’’ domain, but
not in the other domains.These results suggest that, at
least in moderate-to-severe asthmatics, the educational
program could determine a noticeable clinical e¡ect in
the QOL.
Although other results were statistically signi¢cant,
the lack of an improvementX0.5 might be explained by
the fact that the baseline QOLwas quite high in this po-
pulation making great changes unlikely in such a short
period of time.
Guyatt et al. recently suggested another way to inter-
pret QOL results (11). The index used is the number of
patients needed to treat (NNT) for a single patient ben-
e¢t. In our study, similar NNTwere found in the ‘‘Symp-
toms’’,‘‘Activities’’,‘‘Environment’’ and ‘‘Overall’’ domains,with values ranging from 3.1to 4.3, while the NNT in the
‘‘Emotions’’ domain was higher. Therefore, for example,
for every 20 patients completing the educational pro-
gram six showed an improvement in the‘‘Symptoms’’ do-
main, four in the ‘‘Activities’’ and overall domains, and
only one in the ‘‘Emotions’’ domain. This con¢rms that
the e¡ect of the educational program on QOL may be
incomplete and not fully uniform in each domain.
We are actually unable to determine which aspect of
the educational program was primarily responsible for
the improvements we found.Knowingmore about asth-
ma, trigger factors, medication use and management of
exacerbations is an important part of the program but,
in our opinion the partnership between patient and doc-
tormight be the determining factor. As was pointed out
in a recent paper (17), in the so-called co-management
model,‘‘the physician assumes the role of consultant and
teacher, eliciting and addressing patients’ fears and con-
cerns about the disease and the use of medication’’.
Therefore, the physician not only provides information,
but also helps to develop the patient’s skills in controlling
the disease, shares responsibilitieswithhim and together
they come to a mutual agreement on therapy. Thus, we
would expect such an approach to increase the likeli-
hood of better diseasemanagement.
The education programwas not e¡ective in any of the
other morbidity parameters (symptom-free days, use of
rescue salbutamol, days absent from school or work).
Even if most of the previous studies were able to show
improvement in some morbidity outcomes (18^20), re-
sults similar to ours have been reported (21^23). Di¡er-
ences in patient selection could partly explain these
discrepancies. In fact, unlike our subjects the patients in-
cluded in some studies (18^20) were very high-risk sub-
jects (hospitalized because of asthma (19) or a¡ected by
severe (20) or refractory to treatment (18) asthma).
Moreover, baseline values of some of the morbidity out-
comes in our subjects were indicative of a group of pa-
tients whose asthma was well controlled (many
symptom free days and few days of absence from work
or school). However, 3 months after the educational
program, the lack of di¡erences between Groups A and
B was quite surprising but, as Cote et al. commented,
(22) controls did receive some sort of education during
the study along with more than the usual attention (i.e.
longer visits, more answers to questions, and adminis-
tration of the QOL questionnaire), thereby reducing
the likelihood of major di¡erences.
Even if the di¡erence was not statistically signi¢cant,
more use of rescue salbutamolwas observed in Group B
because of the marked increase in b2-agonist use re-
ported by three of the 37 subjects in the group. Since
no other signs of asthma exacerbation were present in
these patients we can, like others (15), presume that the
educational program taught them a more appropriate
use of rescue salbutamol.
998 RESPIRATORYMEDICINEThe only objective parameter ofmorbidity, whichwas
statistically higher in the educational group than in the
control group, was FEV1, even after adjustment for base-
line FEV1.This ¢nding was observed only in subjectswith
moderate or severe asthma, thus con¢rming the e¡ec-
tiveness of the educational program only in these asth-
matic patients. Although similar observations have been
reported elsewhere (4,7,20), other studies failed to ¢nd
such an improvement (21,24).Rather thanoveremphasize
this ¢nding, as the follow-up period was short and the
number of subjects not high, it is reasonable to suggest
that an improvement in objective variables, such as FEV1
needs to be con¢rmed in other studies and in longer fol-
low-ups.
In conclusion, the educational program improved
the quality of life, mainly in patients with moderate-
to-severe asthma. More patients need to be followed-
up for a longer period of time to con¢rm these
¢ndings.
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